|Follow us :|
Luai Al Bakour
El Temamy Pharmacy
Akoni Hijyen Teknolojileri Sanayi ve Dış Ticaret LTD. ŞTİ
Britton Chance Center for Biomedical Photonics
Arabian Trade Center - ATC
Medical Facility (32206):
Legality International. (Pvt.) Ltd.
MainYou must sign in to use this servcie
Feedback - Please use the form below to send your query or comment
You must sign in to use this servcie
Passive, transient protection against tetanus in any person that may be contaminated with tetanus spores when: (1) patient's personal history of immunization with tetanus toxoid is unknown or uncertain, (2) person received less than 2 prior doses of tetanus toxoid, or (3) person received 2 prior doses of tetanus toxoid, but delay of more than 24 h occurred between time of injury and initiation of tetanus prophylaxis.
Hypersensitivity to human antibody product, thimerosal, or other components; circulating anti-IgA antibodies.
Local and systemic reactions following TIG are infrequent and usually mild. Expect some pain, tenderness, and muscle stiffness at injection site, persisting for several hours. Hives, angioedema, nephrotic syndrome, and local inflammation occur occasionally. Anaphylactic reactions are very infrequent.
There is no significant interaction between TIG and tetanus toxoid if given at different injection sites. To avoid inactivating vaccines containing live viruses or bacteria, give live vaccines 2 to 4 wk before or 12 wk after TIG
Pregnancy Category C . Lactation Undetermined. Use TIG as soon as possible after tetanus-prone injuries. Do not inject IV.
SOLUTION FOR INJECTION
Dosage and AdministrationYou must sign in to use this servcie
Technical DescriptionYou must sign in to use this servcie
Dr. Faisal Dibsi
Dr. Hani Najjar
Samir Moussa M.D.
Dr . Dirar Abboud
Dr. Tahsin Martini
Dr. Talal Sabouni
Yaser Habrawi , F.R.C.S.Ed
Dr. Samer Al-Jneidy